{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T20:22:42Z","timestamp":1776975762194,"version":"3.51.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s42000-021-00289-z","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T10:03:14Z","timestamp":1621936994000},"page":"449-461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Higher ovulation rate with letrozole as compared with clomiphene citrate in infertile women with polycystic ovary syndrome: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"20","author":[{"given":"Alexandra P.","family":"Tsiami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios G.","family":"Goulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros I.","family":"Sotiriadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstratios M.","family":"Kolibianakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,25]]},"reference":[{"issue":"12","key":"289_CR1","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1056\/NEJMra041536","volume":"352","author":"DA Ehrmann","year":"2005","unstructured":"Ehrmann DA (2005) Polycystic ovary syndrome. N Engl J Med 352(12):1223\u20131236. https:\/\/doi.org\/10.1056\/NEJMra041536","journal-title":"N Engl J Med"},{"issue":"6","key":"289_CR2","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89(6):2745\u20132749. https:\/\/doi.org\/10.1210\/jc.2003-032046","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"289_CR3","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO (2016) The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31(12):2841\u20132855. https:\/\/doi.org\/10.1093\/humrep\/dew218","journal-title":"Hum Reprod"},{"issue":"3","key":"289_CR4","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/humrep\/dem426","volume":"23","author":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2008","unstructured":"Thessaloniki ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2008) Consensus on infertility treatment related to polycystic ovary syndrome [published correction appears in Hum Reprod. 2008 Jun;23(6):1474]. Hum Reprod 23(3):462\u2013477. https:\/\/doi.org\/10.1093\/humrep\/dem426","journal-title":"Hum Reprod"},{"issue":"5","key":"289_CR5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/humupd\/dms019","volume":"18","author":"ESHRE Capri Workshop Group","year":"2012","unstructured":"ESHRE Capri Workshop Group (2012) Health and fertility in World Health Organization group 2 anovulatory women. Hum Reprod Update 18(5):586\u2013599. https:\/\/doi.org\/10.1093\/humupd\/dms019","journal-title":"Hum Reprod Update"},{"issue":"6","key":"289_CR6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","volume":"22","author":"AH Balen","year":"2016","unstructured":"Balen AH, Morley LC, Misso M et al (2016) The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update 22(6):687\u2013708. https:\/\/doi.org\/10.1093\/humupd\/dmw025","journal-title":"Hum Reprod Update"},{"issue":"11","key":"289_CR7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.6061\/clinics\/2015(11)09","volume":"70","author":"AS Melo","year":"2015","unstructured":"Melo AS, Ferriani RA, Navarro PA (2015) Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Clinics (Sao Paulo) 70(11):765\u2013769. https:\/\/doi.org\/10.6061\/clinics\/2015(11)09","journal-title":"Clinics (Sao Paulo)"},{"key":"289_CR8","doi-asserted-by":"publisher","unstructured":"O\u2019Flynn N (2014) Assessment and treatment for people with fertility problems: NICE guideline. Br J Gen Pract 64(618):50\u201351. https:\/\/doi.org\/10.3399\/bjgp14X676609","DOI":"10.3399\/bjgp14X676609"},{"issue":"9","key":"289_CR9","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s40618-015-0274-y","volume":"38","author":"P Moghetti","year":"2015","unstructured":"Moghetti P, Carmina E, De Leo V et al (2015) How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology. J Endocrinol Invest 38(9):1025\u20131037. https:\/\/doi.org\/10.1007\/s40618-015-0274-y","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"289_CR10","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA et al (2013) Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 98(12):4565\u20134592. https:\/\/doi.org\/10.1210\/jc.2013-2350","journal-title":"J Clin Endocrinol Metab"},{"key":"289_CR11","doi-asserted-by":"publisher","unstructured":"Teede HJ, Norman RJ, Garad RM (2019) A new evidence\u2010based guideline for assessment and management of polycystic ovary syndrome. Med J Aust 210(6): https:\/\/doi.org\/10.5694\/mja2.50053","DOI":"10.5694\/mja2.50053"},{"key":"289_CR12","unstructured":"International evidence based guidelines for the assessment and management of polycystic ovary syndrome 2018. Australlian Clinical Practice Guidelines"},{"key":"289_CR13","doi-asserted-by":"publisher","unstructured":"Homburg R (2010) Choices in the treatment of anovulatory PCOS. Current management of polycystic ovary syndrome. Edited by Adam Balen, Steve Franks and Roy Homburg. Proceedings of 59th RCOG Study Group, RCOG Press, London Cambridge University Press; pp 143\u2013152. https:\/\/doi.org\/10.1017\/CBO9781107478343","DOI":"10.1017\/CBO9781107478343"},{"issue":"8","key":"289_CR14","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1093\/humrep\/dei042","volume":"20","author":"R Homburg","year":"2005","unstructured":"Homburg R (2005) Clomiphene citrate\u2013end of an era? A mini-review. Hum Reprod 20(8):2043\u20132051. https:\/\/doi.org\/10.1093\/humrep\/dei042","journal-title":"Hum Reprod"},{"issue":"10","key":"289_CR15","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1093\/humrep\/dei128","volume":"20","author":"IE Messinis","year":"2005","unstructured":"Messinis IE (2005) Ovulation induction: a mini review. Hum Reprod 20(10):2688\u20132697. https:\/\/doi.org\/10.1093\/humrep\/dei128","journal-title":"Hum Reprod"},{"issue":"2","key":"289_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0015-0282(97)81907-3","volume":"67","author":"Y Nakamura","year":"1997","unstructured":"Nakamura Y, Ono M, Yoshida Y, Sugino N, Ueda K, Kato H (1997) Effects of clomiphene citrate on the endometrial thickness and echogenic pattern of the endometrium. Fertil Steril 67(2):256\u2013260. https:\/\/doi.org\/10.1016\/S0015-0282(97)81907-3","journal-title":"Fertil Steril"},{"issue":"3","key":"289_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/s0015-0282(16)54541-5","volume":"56","author":"JM Randall","year":"1991","unstructured":"Randall JM, Templeton A (1991) Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles. Fertil Steril. 56(3):465\u2013468. https:\/\/doi.org\/10.1016\/s0015-0282(16)54541-5","journal-title":"Fertil Steril."},{"issue":"11","key":"289_CR18","first-page":"2291","volume":"9","author":"Z Hussein","year":"2017","unstructured":"Hussein Z, Al-Obaidi MT, AL-Saadi WI, Selman MO (2017) Comparison of the effect of clomiphene citrate and letrozole on the endometrial parameters of PCOS women. J Pharm Sci Res 9(11):2291\u20132295","journal-title":"J Pharm Sci Res"},{"issue":"4","key":"289_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/humupd\/3.4.359","volume":"3","author":"E Kousta","year":"1997","unstructured":"Kousta E, White DM, Franks S (1997) Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update. 3(4):359\u2013365. https:\/\/doi.org\/10.1093\/humupd\/3.4.359","journal-title":"Hum Reprod Update."},{"key":"289_CR20","doi-asserted-by":"publisher","unstructured":"Brown J, Farquhar C, Beck J, Boothroyd C, Hughes E (2009) Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database Syst Rev (4):CD002249. https:\/\/doi.org\/10.1002\/14651858.CD002249.pub4. Published 2009 Oct 7","DOI":"10.1002\/14651858.CD002249.pub4."},{"issue":"2","key":"289_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/s0015-0282(00)01705-2","volume":"75","author":"MF Mitwally","year":"2001","unstructured":"Mitwally MF, Casper RF (2001) Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 75(2):305\u2013309. https:\/\/doi.org\/10.1016\/s0015-0282(00)01705-2","journal-title":"Fertil Steril"},{"issue":"8","key":"289_CR22","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/humrep\/dex227","volume":"32","author":"SA Amer","year":"2017","unstructured":"Amer SA, Smith J, Mahran A, Fox P, Fakis A (2017) Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Hum Reprod 32(8):1631\u20131638. https:\/\/doi.org\/10.1093\/humrep\/dex227","journal-title":"Hum Reprod"},{"issue":"2","key":"289_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1056\/NEJMoa1313517","volume":"371","author":"RS Legro","year":"2014","unstructured":"Legro RS, Brzyski RG, Diamond MP et al (2014) Letrozole versus clomiphene for infertility in the polycystic ovary syndrome [published correction appears in N Engl J Med. 2014;317(15):1465]. N Engl J Med. 371(2):119\u2013129. https:\/\/doi.org\/10.1056\/NEJMoa1313517","journal-title":"N Engl J Med."},{"issue":"6","key":"289_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.rbmo.2016.03.006","volume":"32","author":"K Birch Petersen","year":"2016","unstructured":"Birch Petersen K, Pedersen NG, Pedersen AT, Lauritsen MP, la Cour FN (2016) Mono-ovulation in women with polycystic ovary syndrome: a clinical review on ovulation induction. Reprod Biomed Online 32(6):563\u2013583. https:\/\/doi.org\/10.1016\/j.rbmo.2016.03.006","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"289_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.fertnstert.2015.01.011","volume":"103","author":"RS Usadi","year":"2015","unstructured":"Usadi RS, Merriam KS (2015) On-label and off-label drug use in the treatment of female infertility. Fertil Steril 103(3):583\u2013594. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.01.011","journal-title":"Fertil Steril"},{"issue":"5","key":"289_CR26","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1210\/jc.2014-4235","volume":"100","author":"S Palomba","year":"2015","unstructured":"Palomba S (2015) Aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab 100(5):1742\u20131747. https:\/\/doi.org\/10.1210\/jc.2014-4235","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl1","key":"289_CR27","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/j.fertnstert.2005.07.230","volume":"84","author":"MM Biljan","year":"2005","unstructured":"Biljan MM, Hemmings R, Brassard N (2005) The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Sreril 84(Suppl1):S95. https:\/\/doi.org\/10.1016\/j.fertnstert.2005.07.230","journal-title":"Fertil Sreril"},{"issue":"8","key":"289_CR28","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/s1701-2163(16)32551-8","volume":"29","author":"R Forman","year":"2007","unstructured":"Forman R, Gill S, Moretti M, Tulandi T, Koren G, Casper R (2007) Fetal safety of letrozole and clomiphene citrate for ovulation induction. J Obstet Gynaecol Can 29(8):668\u2013671. https:\/\/doi.org\/10.1016\/s1701-2163(16)32551-8","journal-title":"J Obstet Gynaecol Can"},{"issue":"6","key":"289_CR29","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.fertnstert.2006.03.014","volume":"85","author":"T Tulandi","year":"2006","unstructured":"Tulandi T, Martin J, Al-Fadhli R et al (2006) Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 85(6):1761\u20131765. https:\/\/doi.org\/10.1016\/j.fertnstert.2006.03.014","journal-title":"Fertil Steril"},{"key":"289_CR30","doi-asserted-by":"publisher","unstructured":"Sharma S, Ghosh S, Singh S, et al (2014) Congenital malformations among babies born following letrozole or clomiphene for infertility treatment. PLoS One 9(10):e108219. Published 2014 Oct 1. https:\/\/doi.org\/10.1371\/journal.pone.0108219","DOI":"10.1371\/journal.pone.0108219"},{"issue":"12","key":"289_CR31","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3109\/09513590.2015.1096337","volume":"31","author":"M Roque","year":"2015","unstructured":"Roque M, Tostes AC, Valle M, Sampaio M, Geber S (2015) Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysis. Gynecol Endocrinol 31(12):917\u2013921. https:\/\/doi.org\/10.3109\/09513590.2015.1096337","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"289_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/uog.18933","volume":"51","author":"MA Gadalla","year":"2018","unstructured":"Gadalla MA, Huang S, Wang R, Norman RJ, Abdullah SA, El Saman AM, Ismail AM, van Wely M, Mol BWJ (2018) Effect of clomiphene citrate on endometrial thickness, ovulation, pregnancy and live birth in anovulatory women: systematic review and meta-analysis. Ultrasound Obstet Gynecol 51(1):64\u201376. https:\/\/doi.org\/10.1002\/uog.18933","journal-title":"Ultrasound Obstet Gynecol"},{"key":"289_CR33","doi-asserted-by":"publisher","unstructured":"Franik S, Eltrop SM, Kremer JA, Kiesel L, Farquhar C (2018) Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev 5. https:\/\/doi.org\/10.1002\/14651858.CD010287","DOI":"10.1002\/14651858.CD010287"},{"issue":"3","key":"289_CR34","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/humupd\/dms003","volume":"18","author":"ML Misso","year":"2012","unstructured":"Misso ML, Wong JL, Teede HJ, Hart R, Rombauts L, Melder AM, Norman RJ, Costello MF (2012) Aromatase inhibitors for PCOS: a systematic review and meta-analysis. Human Reprod Update 18(3):301\u2013312. https:\/\/doi.org\/10.1093\/humupd\/dms003","journal-title":"Human Reprod Update"},{"key":"289_CR35","doi-asserted-by":"publisher","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.005","DOI":"10.1016\/j.jclinepi.2009.06.005"},{"key":"289_CR36","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898","journal-title":"BMJ"},{"key":"289_CR37","unstructured":"McMaster University (2015) (developed by Evidence Prime, Inc.). GRADEpro GDT: GRADEpro Guideline Development Tool [Software].\u00a0https:\/\/gradepro.org\/. Accessed 23 Jan 2021"},{"key":"289_CR38","unstructured":"OpenMetaAnalyst_win 8 Software"},{"key":"289_CR39","unstructured":"Borenstein M, Hedges L, Higgins J, Rothstein H (2013) Biostat, Englewood, NJ Comprehensive Meta-Analysis Version 3"},{"key":"289_CR40","doi-asserted-by":"publisher","unstructured":"McGuinness, LA, Higgins, JPT (2020) Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Syn Meth. 1-7. https:\/\/doi.org\/10.1002\/jrsm.1411","DOI":"10.1002\/jrsm.1411"},{"issue":"1","key":"289_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/147323000603400109","volume":"34","author":"V Atay","year":"2006","unstructured":"Atay V, Cam C, Muhcu M, Cam M, Karateke A (2006) Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. J Int Med Res 34(1):73\u201376. https:\/\/doi.org\/10.1177\/147323000603400109","journal-title":"J Int Med Res"},{"key":"289_CR42","first-page":"195","volume":"29","author":"EM Aygen","year":"2007","unstructured":"Aygen EM, Guzel Z, Ozgun T, Atakul T, Sahin Y (2007) The use of letrozole for ovulation induction in infertile women with polycystic ovarian syndrome. Erciyes Med Journal 29:195\u2013200","journal-title":"Erciyes Med Journal"},{"key":"289_CR43","doi-asserted-by":"crossref","unstructured":"Abd EL Fatah AGK, Abd El Salam Wafa Y, Labib MM (2017) Role of letrozole versus clomiphene citrate in induction of ovulation in patients with polycystic ovarian syndrome. J Gynecol Reprod Med 1","DOI":"10.33140\/JGRM\/01\/01\/00010"},{"issue":"3","key":"289_CR44","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.fertnstert.2007.02.062","volume":"92","author":"A Badawy","year":"2009","unstructured":"Badawy A, Abdel Aal I, Abulatta M (2009) Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. Fertil Steril 92(3):849\u2013852. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.02.062","journal-title":"Fertil Steril"},{"issue":"5","key":"289_CR45","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.fertnstert.2006.04.026","volume":"86","author":"U Bayar","year":"2006","unstructured":"Bayar U, Basaran M, Kiran S, Coskun A, Gezer S (2006) Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertil Steril 86(5):1447\u20131451. https:\/\/doi.org\/10.1016\/j.fertnstert.2006.04.026","journal-title":"Fertil Steril"},{"issue":"3","key":"289_CR46","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.fertnstert.2007.08.044","volume":"92","author":"MR Begum","year":"2009","unstructured":"Begum MR, Ferdous J, Begum A, Quadir E (2009) Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertil Steril 92(3):853\u2013857. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.08.044","journal-title":"Fertil Steril"},{"issue":"3","key":"289_CR47","first-page":"335","volume":"6","author":"N Behnoud","year":"2019","unstructured":"Behnoud N, Farzaneh F, Ershadi S (2019) the effect of clomiphene citrate versus letrozole on pregnancy rate in women with polycystic ovary syndrome: a randomized clinical trial. Crescent J Med Biol Sci 6(3):335\u2013340","journal-title":"Crescent J Med Biol Sci"},{"issue":"6","key":"289_CR48","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.12669\/pjms.326.11391","volume":"32","author":"Z Chen","year":"2016","unstructured":"Chen Z, Zhang M, Qiao Y, Yang J (2016) Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. Pak J Med Sci 32(6):1434\u20131438. https:\/\/doi.org\/10.12669\/pjms.326.11391","journal-title":"Pak J Med Sci"},{"key":"289_CR49","first-page":"23","volume":"34","author":"S Dehbashi","year":"2009","unstructured":"Dehbashi S, Kazerooni T, Robati M, Alborzi S, Parsanezhad ME, Shadman A (2009) Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iran J Med Sci 34:23\u201328","journal-title":"Iran J Med Sci"},{"key":"289_CR50","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4103\/2277-9175.175237","volume":"5","author":"A Ghahiri","year":"2016","unstructured":"Ghahiri A, Mogharehabed N, Mamourian M (2016) Letrozole as the first-line treatment of infertile women with poly cystic ovarian syndrome (PCOS) compared with clomiphene citrate: A clinical trial. Adv Biomed Res 5:6. https:\/\/doi.org\/10.4103\/2277-9175.175237","journal-title":"Adv Biomed Res"},{"issue":"11","key":"289_CR51","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1080\/09513590.2017.1332174","volume":"33","author":"C Liu","year":"2017","unstructured":"Liu C, Feng G, Huang W et al (2017) Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial. Gynecol Endocrinol 33(11):872\u2013876. https:\/\/doi.org\/10.1080\/09513590.2017.1332174","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"289_CR52","doi-asserted-by":"publisher","first-page":"88","DOI":"10.5530\/ami.2016.2.19","volume":"3","author":"AA Moussa","year":"2016","unstructured":"Moussa AA, Torky H, Dief O, Elwahed AA, Senna HA (2016) The effect of clomiphene citrate versus tamoxifen versus letrozol on endometrial thickness and blood flow in ovulation induction in women with polycystic ovaries. Acta Medica International 3(2):88\u201392. https:\/\/doi.org\/10.5530\/ami.2016.2.19","journal-title":"Acta Medica International"},{"issue":"3","key":"289_CR53","first-page":"253","volume":"64","author":"L Nahid","year":"2012","unstructured":"Nahid L, Sirous K (2012) Comparison of the effects of letrozole and clomiphene citrate for ovulation induction in infertile women with polycystic ovary syndrome. Minerva Ginecol 64(3):253\u2013258","journal-title":"Minerva Ginecol"},{"issue":"3","key":"289_CR54","first-page":"879","volume":"6","author":"H Nazik","year":"2012","unstructured":"Nazik H, Kumtepe Y (2012) Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome. Health Med 6(3):879\u2013883","journal-title":"Health Med"},{"key":"289_CR55","doi-asserted-by":"publisher","unstructured":"Nik Hussain \u039d\u039a, Ismail \u039c, Zain \u039c\u039c, Yeu PC, Wan Mohammad (2013) Randomized controlled trial of letrozole versus clomiphene citrate for induction of ovulation in polycystic ovarian syndrome (PCOS) a Malaysian experience. Open J Obstet Gynecol, 3:11\u201317. https:\/\/doi.org\/10.4236\/ojog.2013.35A2003","DOI":"10.4236\/ojog.2013.35A2003"},{"issue":"3","key":"289_CR56","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00404-011-2091-7","volume":"285","author":"PB Ray","year":"2012","unstructured":"Ray PB, Ray A, Chakraborti PS (2012) Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome. Arch Gynecol Obstet 285(3):873\u2013877. https:\/\/doi.org\/10.1007\/s00404-011-2091-7","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"289_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/0974-1208.97789","volume":"5","author":"KK Roy","year":"2012","unstructured":"Roy KK, Baruah J, Singla S et al (2012) A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. J Hum Reprod Sci 5(1):20\u201325. https:\/\/doi.org\/10.4103\/0974-1208.97789","journal-title":"J Hum Reprod Sci"},{"issue":"6","key":"289_CR58","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1089\/gyn.2012.0033","volume":"28","author":"MF Selim","year":"2012","unstructured":"Selim MF, Borg TF (2012) Letrozole and clomiphene citrate effect on endometrial and subendometrial vascularity in treating infertility in women with polycystic ovary syndrome. J Gynecol Surg 28(6):405\u2013410. https:\/\/doi.org\/10.1089\/gyn.2012.0033","journal-title":"J Gynecol Surg"},{"issue":"11","key":"289_CR59","first-page":"1149","volume":"65","author":"M Sharief","year":"2015","unstructured":"Sharief M, Nafee NR (2015) Comparison of letrazole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. J Pak Med Assoc 65(11):1149\u20131152","journal-title":"J Pak Med Assoc"},{"key":"289_CR60","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.mefs.2010.11.004","volume":"16","author":"M Sheikh-El-Arab Elsedeek","year":"2011","unstructured":"Sheikh-El-Arab Elsedeek M, Elmaghraby HAH (2011) Predictors and characteristics of letrozole induced ovulation in comparison with clomiphene induced ovulation in anovulatory PCOS women. Middle East Fertil Soc J 16:125\u2013130. https:\/\/doi.org\/10.1016\/j.mefs.2010.11.004","journal-title":"Middle East Fertil Soc J"},{"issue":"10","key":"289_CR61","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1080\/09513590.2019.1612358","volume":"35","author":"L Wang","year":"2019","unstructured":"Wang L, Wen X, Lv S, Zhao J, Yang T, Yang X (2019) Comparison of endometrial receptivity of clomiphene citrate versus letrozole in women with polycystic ovary syndrome: a randomized controlled study. Gynecol Endocrinol 35(10):862\u2013865. https:\/\/doi.org\/10.1080\/09513590.2019.1612358","journal-title":"Gynecol Endocrinol"},{"key":"289_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4137\/CMRH.S6598","volume":"5","author":"SF Hendawy","year":"2011","unstructured":"Hendawy SF, Samaha HE, Elkholy MF (2011) Letrozole versus clomiphene citrate for induction of ovulation in patients with polycystic ovarian syndrome undergoing intrauterine insemination. Clin Med Insights Reprod Health 5:11\u201316. https:\/\/doi.org\/10.4137\/CMRH.S6598","journal-title":"Clin Med Insights Reprod Health"},{"issue":"3","key":"289_CR63","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4103\/0974-1208.106338","volume":"5","author":"S Kar","year":"2012","unstructured":"Kar S (2012) Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: a prospective randomized trial. J Hum Reprod Sci 5(3):262\u2013265. https:\/\/doi.org\/10.4103\/0974-1208.106338","journal-title":"J Hum Reprod Sci"},{"issue":"1\u20132","key":"289_CR64","first-page":"36","volume":"55","author":"M Zeinalzadeh","year":"2010","unstructured":"Zeinalzadeh M, Basirat Z, Esmailpour M (2010) Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. J Reprod Med 55(1\u20132):36\u201340","journal-title":"J Reprod Med"},{"issue":"1","key":"289_CR65","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.rbmo.2011.03.024","volume":"23","author":"D He","year":"2011","unstructured":"He D, Jiang F (2011) Meta-analysis of letrozole versus clomiphene citrate in polycystic ovary syndrome. Reprod Biomed Online 23(1):91\u201396. https:\/\/doi.org\/10.1016\/j.rbmo.2011.03.024","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"289_CR66","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00404-018-4688-6","volume":"297","author":"S Hu","year":"2018","unstructured":"Hu S, Yu Q, Wang Y, Wang M, Xia W, Zhu C (2018) Letrozole versus clomiphene citrate in polycystic ovary syndrome: a meta-analysis of randomized controlled trials. Arch Gynecol Obstet 297(5):1081\u20131088. https:\/\/doi.org\/10.1007\/s00404-018-4688-6","journal-title":"Arch Gynecol Obstet"},{"key":"289_CR67","unstructured":"Casper R, Mitwally M. Ovulation induction with Letrozole. UpToDate Nov 2020"},{"key":"289_CR68","doi-asserted-by":"publisher","unstructured":"Tiboni GM (2004) Aromatase inhibitors and teratogenesis. Fertil Steril 81(4):1158\u20139; author reply 1159.https:\/\/doi.org\/10.1016\/j.fertnstert.2004.01.006","DOI":"10.1016\/j.fertnstert.2004.01.006"},{"issue":"6","key":"289_CR69","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/jog.13644","volume":"44","author":"A AkbariSene","year":"2018","unstructured":"AkbariSene A, Ghorbani S, Ashrafi M (2018) Comparison of the pregnancy outcomes and the incidence of fetal congenital abnormalities in infertile women treated with letrozole and clomiphene citrate. J Obstet Gynaecol Res 44(6):1036\u20131041. https:\/\/doi.org\/10.1111\/jog.13644","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"289_CR70","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/humrep\/dew280","volume":"32","author":"T Tatsumi","year":"2017","unstructured":"Tatsumi T, Jwa SC, Kuwahara A, Irahara M, Kubota T, Saito H (2017) No increased risk of major congenital anomalies or adverse pregnancy or neonatal outcomes following letrozole use in assisted reproductive technology. Hum Reprod 32(1):125\u2013132. https:\/\/doi.org\/10.1093\/humrep\/dew280","journal-title":"Hum Reprod"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-021-00289-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-021-00289-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-021-00289-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T13:20:15Z","timestamp":1672233615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-021-00289-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,25]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["289"],"URL":"https:\/\/doi.org\/10.1007\/s42000-021-00289-z","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,25]]},"assertion":[{"value":"15 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}